Silverfin false false 29/02/2024 29/02/2024 16/02/2023 The principal activity of the Company during the financial period was medical consultancy. Monika Hofer 16/02/2023 Daniel John Royston 16/02/2023 14667622 2024-02-29 14667622 bus:Director1 2024-02-29 14667622 bus:Director2 2024-02-29 14667622 core:CurrentFinancialInstruments 2024-02-29 14667622 2023-02-16 2024-02-29 14667622 bus:Micro-entities 2023-02-16 2024-02-29 14667622 bus:FilletedAccounts 2023-02-16 2024-02-29 14667622 bus:AuditExemptWithAccountantsReport 2023-02-16 2024-02-29 14667622 bus:PrivateLimitedCompanyLtd 2023-02-16 2024-02-29 14667622 bus:Director1 2023-02-16 2024-02-29 14667622 bus:Director2 2023-02-16 2024-02-29 iso4217:GBP xbrli:pure

Company No: 14667622 (England and Wales)

HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

Unaudited Financial Statements
For the financial period from 16 February 2023 to 29 February 2024
Pages for filing with the registrar

HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial period from 16 February 2023 to 29 February 2024

Contents

HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

BALANCE SHEET

As at 29 February 2024
HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

BALANCE SHEET (continued)

For the financial period from 16 February 2023 to 29 February 2024
29.02.2024
£
Fixed assets 9,028
Current assets 34,970
Prepayments and accrued income 948
Creditors: amounts falling due within one year ( 9,434)
Net current assets 26,484
Total assets less current liabilities 35,512
Accruals and deferred income ( 2,760)
Net assets 32,752
Capital and reserves 32,752

For the financial period ending 29 February 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hofer-Royston Medical Consultancy Limited (registered number: 14667622) were approved and authorised for issue by the Board of Directors on 15 November 2024 and were signed on its behalf by:

Monika Hofer
Director
Daniel John Royston
Director
HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 16 February 2023 to 29 February 2024
HOFER-ROYSTON MEDICAL CONSULTANCY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial period from 16 February 2023 to 29 February 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 14667622). The address of its registered office is 264 Banbury Road, Oxford, OX2 7DY, England, United Kingdom.

2. Employees

Period from
16.02.2023 to
29.02.2024
Number
Monthly average number of persons employed by the Company during the financial period, including directors 2